Low-dose anticoagulation in Chinese patients with mechanical heart valves

Asian Cardiovascular and Thoracic Annals

Volumn 13, Issue 4, 2005, Pages 341-344

  Zhou, Xin Min ^a   Zhuang, Wei ^a   Hu, Jian Guo ^a   Li, Jian Min ^a   Yu, Jie Feng ^a   Jiang, Ling ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; HEPARIN; WARFARIN;

ADOLESCENT; ADULT; ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMORRHAGE; CHINESE; CONJUNCTIVAL HEMORRHAGE; EPISTAXIS; FEMALE; FOLLOW UP; HEART VALVE REPLACEMENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT MONITORING; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; SUBCUTANEOUS TISSUE; THROMBOEMBOLISM;

EID: 29244435854     PISSN: 02184923     EISSN: None     Source Type: Journal    
DOI: 10.1177/021849230501300410     Document Type: Article

References (9)

1. Edmunds LH Jr, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. The American Association for Thoracic Surgery, Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity. Ann Thorac Surg 1996;62:932-5.
2. Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994;89:635-41.
3. Stein PD, Alpert JS, Copeland J, Dalen JE, Goldman S, Turpie AG. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 1992;102(4 Suppl):445S-55S.
4. Cortelazzo S, Finazzi G, Viero P, Galli M, Remuzzi A, Parenzan L, Barbui T. Thrombolic and hemorrhagic complications in patients with mechanical heart valve prothesis attending an anticoagulation clinic. Thromb Haemost 1993;69:316-20.
5. Hirsh J, Dalen J, Guyatt G; American College of Chest Physicians. The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis. American College of Chest Physicians. Chest 2001;119(1 Suppl):1S-2S.
6. Mori T, Asano M, Ohtake H, Bitoh A, Sekiguchi S, Matsuo Y, et al. Anticoagulant therapy after prosthetic valve replacement-optimal PT-INR in Japanese patients. Ann Thorac Cardiovasc Surg 2002;8:83-7.
7. Uetsuka Y, Hosoda S, Kasanuki H, Aosaki M, Murasaki K, Ooki K, et al. Optimal therapeutic range for oral anticoagulants in Japanese patients with prosthetic heart valves: a preliminary report from a single institution using conversion from thrombotest to PT-INR. Heart Vessels 2000;15:124-8.
8. Sun X, Hu S, Qi G, Zhou Y. Low standard oral anticoagulation therapy for Chinese patients with St. Jude mechanical heart valves. Chin Med J (Engl) 2003;116:1175-8.
9. Chenhsu RY, Chiang SC, Chou MH, Lin MF. Long-term treatment with warfarin in Chinese population. Ann Pharmacother 2000;34:1395-401.